Arthur Hayes focuses on longevity after the presidential pardon
The post Arthur Hayes focuses on longevity after the presidential pardon appeared on BitcoinEthereumNews.com. Arthur Hayes returns to the spotlight with a significant move: joining the board and acquiring a substantial stake in a company active in the stem cell sector, with the declared goal of tapping into the longevity trend that attracts capital even from the crypto world. The change of scenario would come after a supposed presidential pardon that would have eased operational constraints and redefined his public profile following the well-known events related to BitMEX. According to the data collected by the editorial team, based on research in public records and corporate communications available as of August 21, 2025, there is still no official statement explicitly naming the company involved or the exact percentage of the stake. The industry analysts we consulted note that it is relatively common for crypto family offices to adopt diversify-in-healthcare strategies before formal announcements to the media. In our analysis of public filings (e.g., SEC’s EDGAR database) and registrations in foreign jurisdictions, no public confirmation documents have yet emerged regarding the formal entry into the board. From trading to biomedicine: what Arthur Hayes is doing The co-founder of BitMEX is reportedly reallocating part of the capital towards regenerative medicine, taking on a governance role and acquiring a stake in a company that offers stem cell-based treatments. It should be noted that the information is still partial. According to some rumors, Arthur Hayes has been attending clinics in Mexico and Thailand for over a year, exploring protocols aimed at improving metabolic health and preventing aging. What we know so far (and what remains to be clarified) Role: presence on the board of directors of the company (company name to be verified); Participation: investment described as “relevant” (official percentages are not available); Direct experience: it is rumored that Hayes has received treatments at the same facility where he…

The post Arthur Hayes focuses on longevity after the presidential pardon appeared on BitcoinEthereumNews.com.
Arthur Hayes returns to the spotlight with a significant move: joining the board and acquiring a substantial stake in a company active in the stem cell sector, with the declared goal of tapping into the longevity trend that attracts capital even from the crypto world. The change of scenario would come after a supposed presidential pardon that would have eased operational constraints and redefined his public profile following the well-known events related to BitMEX. According to the data collected by the editorial team, based on research in public records and corporate communications available as of August 21, 2025, there is still no official statement explicitly naming the company involved or the exact percentage of the stake. The industry analysts we consulted note that it is relatively common for crypto family offices to adopt diversify-in-healthcare strategies before formal announcements to the media. In our analysis of public filings (e.g., SEC’s EDGAR database) and registrations in foreign jurisdictions, no public confirmation documents have yet emerged regarding the formal entry into the board. From trading to biomedicine: what Arthur Hayes is doing The co-founder of BitMEX is reportedly reallocating part of the capital towards regenerative medicine, taking on a governance role and acquiring a stake in a company that offers stem cell-based treatments. It should be noted that the information is still partial. According to some rumors, Arthur Hayes has been attending clinics in Mexico and Thailand for over a year, exploring protocols aimed at improving metabolic health and preventing aging. What we know so far (and what remains to be clarified) Role: presence on the board of directors of the company (company name to be verified); Participation: investment described as “relevant” (official percentages are not available); Direct experience: it is rumored that Hayes has received treatments at the same facility where he…
What's Your Reaction?






